Evaluation of pancreatic tumors with positron emission tomography and F-18 fluorodeoxyglucose: comparison with CT and US.
The DOI matches its Crossref record.
Abstract
PURPOSE: To assess the clinical value of positron emission tomography (PET) with fluorine-18-labeled fluorodeoxyglucose (FDG) for identification of pancreatic carcinoma. MATERIALS AND METHODS: Forty-six patients suspected of having a pancreatic neoplasm and who were to undergo surgery prospectively underwent FDG PET, computed tomography (CT), and transabdominal ultrasound (US). Endoscopic US was performed in 40 patients. Images were independently interpreted and compared with the histopathologic findings at surgery (41 patients) or with clinical follow-up findings (five patients). RESULTS: In 33 of 35 patients, foci of pancreatic carcinomas (10-100 mm in diameter) were identified as an increase in FDG uptake, whereas CT, transabdominal US, and endoscopic US depicted the foci in 31, 31, and 28, cases, respectively. Among 11 benign lesions, nine showed no increased FDG uptake (specificity = 82%). Specificities of the other modalities were lower. False-positive findings were obtained in a case of chronic active pancreatitis and in a serous cystadenoma. CONCLUSION: FDG PET, which provides "biochemical" information, is accurate in identifying pancreatic carcinoma and may be a method of choice when imaging equivocal masses detected with other "anatomic" imaging studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
(2001) · PubMed · Cited by 943
Strauss, L. G. (1996) · European Journal of Nuclear Medicine · doi:10.1007/bf01367602 · Cited by 527
Oncological applications of positron emission tomography with fluorine-18 fluorodeoxyglucose
Rigo, P., Paulus, P., Kaschten, B. J., Hustinx, R., Bury, T., Jerusalem, G., Benoit, T., & Foidart-Willems, J. (1996) · European Journal of Nuclear Medicine · doi:10.1007/bf01249629 · Cited by 501
Huang, (. S.-C. (2000) · Nuclear Medicine and Biology · doi:10.1016/s0969-8051(00)00155-4 · Cited by 458
Rose, P. G., Adler, L. P., Rodriguez, M., Faulhaber, P. F., Abdul-Karim, F. W., & Miraldi, F. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.1.41 · Cited by 345
Bar-Shalom, R., Valdivia, A. Y., & Blaufox, M. D. (2000) · Seminars in Nuclear Medicine · doi:10.1053/snuc.2000.7439 · Cited by 340
Bipat, S., Phoa, S. S. K. S., van Delden, O. M., Bossuyt, P. M. M., Gouma, D. J., Lam??ris, J. S., & Stoker, J. (2005) · Journal of Computer Assisted Tomography · doi:10.1097/01.rct.0000164513.23407.b3 · Cited by 272
Effectiveness of Positron Emission Tomography for the Detection of Melanoma Metastases
Holder, W. D., White, R. L., Zuger, J. H., Easton, E. J., & Greene, F. L. (1998) · Annals of Surgery · doi:10.1097/00000658-199805000-00017 · Cited by 264
PET and [18F]-FDG in oncology: A clinical update
Conti, P. S., Lilien, D. L., Hawley, K., Keppler, J., Grafton, S. T., & Bading, J. R. (1996) · Nuclear Medicine and Biology · doi:10.1016/0969-8051(96)00074-1 · Cited by 259
Benign causes of 18-FDG uptake on whole body imaging
Stadalnik, R. C., Bakheet, S. M., & Powe, J. (1998) · Seminars in Nuclear Medicine · doi:10.1016/s0001-2998(98)80038-x · Cited by 191
Zhao, S., Kuge, Y., Tsukamoto, E., Mochizuki, T., Kato, T., Hikosaka, K., Hosokawa, M., Kohanawa, M., & Tamaki, N. (2001) · European Journal of Nuclear Medicine · doi:10.1007/s002590100517 · Cited by 68
Self-citation
Metadata
- Authors
- Inokuma, T., Tamaki, N., Torizuka, T., Magata, Y., Fujii, M., Yonekura, Y., Kajiyama, T., Ohshio, G., Imamura, M., & Konishi, J.
- Venue
- Radiology
- Published
- 1995-05
- Volume
- 195
- Issue
- 2
- Pages
- 345-352
- ISSN
- 0033-8419 (ISSN-L)
- 1527-1315
- OpenAlex
- W2070129086
- Cited by
- 158
- References
- 0
- FWCI
- 10.27
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.